Back to Search Start Over

Hypothalamic free fatty acid receptor-1 regulates whole-body energy balance

Authors :
Nathalia R.V. Dragano
Edward Milbank
Roberta Haddad-Tóvolli
Pablo Garrido-Gil
Eva Nóvoa
Marcos F. Fondevilla
Valentina Capelli
Ariane Maria Zanesco
Carina Solon
Joseane Morari
Leticia Pires
Ánxela Estevez-Salguero
Daniel Beiroa
Ismael González-García
Olga Barca-Mayo
Carlos Diéguez
Ruben Nogueiras
José L. Labandeira-García
Elisabeth Rexen Ulven
Trond Ulven
Marc Claret
Licio A. Velloso
Miguel López
Source :
Molecular Metabolism, Vol 79, Iss , Pp 101840- (2024)
Publication Year :
2024
Publisher :
Elsevier, 2024.

Abstract

Objective: Free fatty acid receptor-1 (FFAR1) is a medium- and long-chain fatty acid sensing G protein-coupled receptor that is highly expressed in the hypothalamus. Here, we investigated the central role of FFAR1 on energy balance. Methods: Central FFAR1 agonism and virogenic knockdown were performed in mice. Energy balance studies, infrared thermographic analysis of brown adipose tissue (BAT) and molecular analysis of the hypothalamus, BAT, white adipose tissue (WAT) and liver were carried out. Results: Pharmacological stimulation of FFAR1, using central administration of its agonist TUG-905 in diet-induced obese mice, decreases body weight and is associated with increased energy expenditure, BAT thermogenesis and browning of subcutaneous WAT (sWAT), as well as reduced AMP-activated protein kinase (AMPK) levels, reduced inflammation, and decreased endoplasmic reticulum (ER) stress in the hypothalamus. As FFAR1 is expressed in distinct hypothalamic neuronal subpopulations, we used an AAV vector expressing a shRNA to specifically knockdown Ffar1 in proopiomelanocortin (POMC) neurons of the arcuate nucleus of the hypothalamus (ARC) of obese mice. Our data showed that knockdown of Ffar1 in POMC neurons promoted hyperphagia and body weight gain. In parallel, these mice developed hepatic insulin resistance and steatosis. Conclusions: FFAR1 emerges as a new hypothalamic nutrient sensor regulating whole body energy balance. Moreover, pharmacological activation of FFAR1 could provide a therapeutic advance in the management of obesity and its associated metabolic disorders.

Details

Language :
English
ISSN :
22128778
Volume :
79
Issue :
101840-
Database :
Directory of Open Access Journals
Journal :
Molecular Metabolism
Publication Type :
Academic Journal
Accession number :
edsdoj.f0b6fdab9da7438abc929ece92bf679e
Document Type :
article
Full Text :
https://doi.org/10.1016/j.molmet.2023.101840